Literature DB >> 3065114

Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes.

M Christie1, M Landin-Olsson, G Sundkvist, G Dahlquist, A Lernmark, S Baekkeskov.   

Abstract

Sera from 40 Swedish children diagnosed as having Type 1 (insulin-dependent) diabetes mellitus during a one year period along with 40 age and geographically matched control subjects were tested for antibodies to a Mr-64,000 islet protein by immunoprecipitation of 35S-methionine-labelled rat islet amphiphilic proteins. Of the 40 diabetic patients, 29 (73%) were found to be positive whereas all 40 control subjects were negative. Samples were also tested for titres of islet cell cytoplasmic antibodies by indirect immunofluorescence on frozen sections of human pancreas. In the diabetic group, 30 of the 40 patients (75%) were positive for islet cell cytoplasmic antibodies compared with 2 of the 40 control subjects (5%). A comparison of levels of antibodies to the Mr-64,000 protein with islet cell cytoplasmic antibodies revealed a weak (rs = 0.46), but significant (p less than 0.01) correlation between the two tests. There was no effect of age or sex on levels of antibodies to the Mr-64,000 protein. These results in population-based diabetic children and control subjects demonstrate a high frequency of antibodies to the Mr-64,000 protein at the time of clinical onset.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3065114     DOI: 10.1007/bf00264766

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  "Cytoplasmic" islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate.

Authors:  R C Nayak; M A Omar; A Rabizadeh; S Srikanta; G S Eisenbarth
Journal:  Diabetes       Date:  1985-06       Impact factor: 9.461

2.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies.

Authors:  E Bonifacio; A Lernmark; R L Dawkins
Journal:  J Immunol Methods       Date:  1988-01-21       Impact factor: 2.303

5.  64,000-Mr autoantigen in type I diabetes. Evidence against its surface location on human islets.

Authors:  P G Colman; I L Campbell; T W Kay; L C Harrison
Journal:  Diabetes       Date:  1987-12       Impact factor: 9.461

6.  Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M L Olsson; G Sundkvist; A Lernmark
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

7.  Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.

Authors:  S Baekkeskov; M Landin; J K Kristensen; S Srikanta; G J Bruining; T Mandrup-Poulsen; C de Beaufort; J S Soeldner; G Eisenbarth; F Lindgren
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

8.  A two-colour immunofluorescence test with a monoclonal human proinsulin antibody improves the assay for islet cell antibodies.

Authors:  O D Madsen; M L Olsson; G Bille; G Sundkvist; A Lernmark; G Dahlqvist; J Ludvigsson
Journal:  Diabetologia       Date:  1986-02       Impact factor: 10.122

9.  Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release.

Authors:  T Kanatsuna; S Baekkeskov; A Lernmark; J Ludvigsson
Journal:  Diabetes       Date:  1983-06       Impact factor: 9.461

10.  Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.

Authors:  B Marner; T Agner; C Binder; A Lernmark; J Nerup; T Mandrup-Poulsen; S Walldorff
Journal:  Diabetologia       Date:  1985-12       Impact factor: 10.122

View more
  29 in total

1.  Autoantibodies to 64,000-M(r) islet cell protein in long-term type 1 (insulin-dependent) diabetic patients.

Authors:  E Kawasaki; R Moriuchi; H Takino; S Okuno; Y Takao; Y Maeda; A Yokota; H Yamamoto; N Chikuba; S Akazawa
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

2.  IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.

Authors:  M S Lan; C Wasserfall; N K Maclaren; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice.

Authors:  John A Gebe; Kellee A Unrath; Ben A Falk; Kouichi Ito; Li Wen; Terri L Daniels; Ake Lernmark; Gerald T Nepom
Journal:  Clin Immunol       Date:  2006-09-18       Impact factor: 3.969

4.  Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients.

Authors:  G Sundkvist; L A Velloso; O Kämpe; S L Rabinowe; S A Ivarsson; B Lilja; F A Karlsson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

5.  Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.

Authors:  W Richter; Y Shi; S Baekkeskov
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.

Authors:  M R Christie; J A Hollands; T J Brown; B K Michelsen; T L Delovitch
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus.

Authors:  B K Michelsen; J S Petersen; E Boel; A Møldrup; T Dyrberg; O D Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  The role of reduced glucose transporter content and glucose metabolism in the immature secretory responses of fetal rat pancreatic islets.

Authors:  S J Hughes
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

Review 9.  Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus.

Authors:  A Lernmark; G Klöppel; D Stenger; C Vathanaprida; K Fält; M Landin-Olsson; D G Baskin; J P Palmer; A M Gown; J S Petersen
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.

Authors:  H Bärmeier; D K McCulloch; J L Neifing; G Warnock; R V Rajotte; J P Palmer; A Lernmark
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.